Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$513M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$412M |
| 3 |
Meta Platforms (Facebook)
META
|
+$354M |
| 4 |
ServiceNow
NOW
|
+$262M |
| 5 |
American Airlines Group
AAL
|
+$259M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Palantir
PLTR
|
+$571M |
| 2 |
Apple
AAPL
|
+$571M |
| 3 |
Netflix
NFLX
|
+$388M |
| 4 |
NVIDIA
NVDA
|
+$313M |
| 5 |
TSMC
TSM
|
+$211M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.32% |
| 2 | Healthcare | 15.28% |
| 3 | Consumer Discretionary | 11.85% |
| 4 | Financials | 11.11% |
| 5 | Industrials | 8.48% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3101
MarketWise
MKTW
$56.9M
| $176K | ﹤0.01% |
17,840
+270
| +2% | +$3.23K |
|
3102
Enlivex Ltd
ENLV
$33.3M
| $176K | ﹤0.01% |
12,086
+1,487
| +14% | +$24.7K |
|
3103
Fulgent Genetics
FLGT
$510M
| $176K | ﹤0.01% |
10,400
-14,500
| -58% | -$247K |
|
3104
Westwater Resources
WWR
$51.9M
| $175K | ﹤0.01% |
316,534
+217,333
| +219% | +$169K |
|
3105
MDxHealth
MDXH
$22.5M
| $174K | ﹤0.01% |
122,200
-900
| -0.7% | -$1.63K |
|
3106
Babcock & Wilcox
BW
$1.4B
| $173K | ﹤0.01% |
257,300
-325,434
| -56% | -$402K |
|
|
VLRS
3107
Controladora Vuela Compania de Aviacion
VLRS
$925M
| $173K | ﹤0.01% |
33,100
-400
| -1% | -$2.87K |
|
|
AHG
3108
Akso Health Group
AHG
$1.13B
| $171K | ﹤0.01% |
145,198
+5,800
| +4% | +$7.65K |
|
|
CODX
3109
Co-Diagnostics
CODX
$5.23M
| $170K | ﹤0.01% |
18,344
-177
| -1% | -$3.38K |
|
3110
Krispy Kreme
DNUT
$557M
| $170K | ﹤0.01% |
+34,493
| New | +$264K |
|
3111
Bank Of The James
BOTJ
$123M
| $170K | ﹤0.01% |
+11,477
| New | +$155K |
|
3112
Katapult Holdings
KPLT
$32.1M
| $168K | ﹤0.01% |
16,397
-2,099
| -11% | -$20.9K |
|
|
ELEV
3113
DELISTED
Elevation Oncology
ELEV
| $168K | ﹤0.01% |
647,300
-956,009
| -60% | -$546K |
|
3114
Toro Corp
TORO
$184M
| $167K | ﹤0.01% |
67,500
-8,975
| -12% | -$24.6K |
|
3115
Surrozen
SRZN
$251M
| $166K | ﹤0.01% |
14,226
+700
| +5% | +$8.14K |
|
3116
IZEA Worldwide
IZEA
$59M
| $165K | ﹤0.01% |
78,403
+1,700
| +2% | +$4.14K |
|
3117
PEDEVCO
PED
$142M
| $164K | ﹤0.01% |
11,714
-2,923
| -20% | -$45.4K |
|
|
FRGE
3118
DELISTED
Forge Global Holdings
FRGE
| $164K | ﹤0.01% |
19,400
-11,022
| -36% | -$127K |
|
3119
NSTS Bancorp
NSTS
$66.7M
| $163K | ﹤0.01% |
14,400
| – | – |
|
3120
Sky Harbour Group
SKYH
$382M
| $160K | ﹤0.01% |
12,325
-67,175
| -84% | -$752K |
|
3121
Comstock
LODE
$235M
| $158K | ﹤0.01% |
64,808
+9,678
| +18% | +$32.1K |
|
3122
First Guaranty Bancshares
FGBI
$158M
| $156K | ﹤0.01% |
20,306
-1,200
| -6% | -$11K |
|
|
RJET
3123
Republic Airways Holdings
RJET
$996M
| $155K | ﹤0.01% |
13,188
+7,694
| +140% | +$132K |
|
|
KLRS
3124
Kalaris Therapeutics
KLRS
$99.7M
| $155K | ﹤0.01% |
19,251
+2,748
| +17% | +$26.9K |
|
3125
GEE Group
JOB
$22.8M
| $152K | ﹤0.01% |
752,741
-393,069
| -34% | -$90.1K |
|
Similar funds
Renaissance Technologies's Q1 2025 Portfolio in Review
As of Q1 2025, Renaissance Technologies held 3,989 positions worth $66.1B, down 2.2% from $67.6B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Renaissance Technologies's Q1 2025 filing shows 456 new, 1,472 increased, 1,441 reduced and 583 closed positions. Its largest new stake was ServiceNow: 1,361,505 shares worth $217M. The largest sale was Palantir, an estimated $571M.
By sector, the portfolio is most concentrated in Technology at 17% of assets, down from 21% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Renaissance Technologies's largest Q1 2025 buy was ServiceNow: 1,361,505 shares worth $217M.
- Renaissance Technologies added most to Broadcom in Q1 2025, an estimated $513M increase.
- Renaissance Technologies's biggest Q1 2025 reduction was Palantir, cutting an estimated $571M.
- Renaissance Technologies fully exited Nike in Q1 2025, selling an estimated $197M.
- Renaissance Technologies's ten largest holdings make up 11% of its $66.1B portfolio in Q1 2025.
- Renaissance Technologies opened 456 new positions and closed 583 in Q1 2025.
- Renaissance Technologies's portfolio value fell 2.2% quarter-over-quarter to $66.1B.
Based on Renaissance Technologies's 13F filing for Q1 2025, filed 14 May 2025.